Skip to content

Signal Propagation and Its Relationship to Cognitive Performance in the Aging Human Brain (Focus or Spread)

Better to Focus or to Spread? Signal Propagation and Its Relationship to Cognitive Performance in the Aging Human Brain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04361760
Enrollment
40
Registered
2020-04-24
Start date
2020-06-25
Completion date
2021-05-18
Last updated
2021-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Aging

Keywords

transcranial magnetic stimulation (TMS), high-density electroencephalography (hd-EEG), simultaneous TMS-hd-EEG, diffusion tensor imaging (DTI), neural dedifferentiation

Brief summary

In the next three decades, the world's population over 60 years old is expected to more than double its size. Even in the absence of an obvious pathology (i.e., healthy aging), advancing age is typically associated with a progressive decline in cognitive performance. Although pathophysiological changes in age-related neurodegenerative disorders have received much attention over the past years, far less is known about the neural processes affecting cognition in healthy ageing. One of these postulated processes is neural dedifferentiation (i.e., a decrease in neural selectivity, by which neural representations of processed information become less univocally distinguishable), possibly accompanied by the recruitment of additional cortical areas in the healthy aging brain. To date, these processes have been extensively studied on the neural level, yet their functional significance for cognitive behaviour remains largely unclear. This project will investigate neural dedifferentiation and its relationship to cognitive performance in the healthy aging brain. To this end, the investigators will use a combination of state-of-the-art technologies including simultaneous transcranial magnetic stimulation (TMS) and high-density electroencephalography (hd-EEG) as well as diffusion tensor imaging (DTI). Perspectives include a better understanding of the relationship between neurophysiological mechanisms and cognitive performance in the healthy aging brain.

Interventions

DEVICEsingle-puls TMS

Medical Device (MD): MagPro X100

DEVICEsham stimulation

Sham stimulation is delivered with a dedicated coil, which is magnetically shielded and thus produces only approx. 20% of the nominal magnetic field. This is not enough to reach and stimulate the cortex, but the produced sound and scalp sensation are the same as with a real TMS coil.

Sponsors

Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Informed consent as documented by signature * Age between 20-30 or 65-75 years * Neurologically healthy, i.e., with no documented or present neurological disease or brain injury * Normal or corrected-to-normal visual acuity

Exclusion criteria

* Any instable medical condition, in particular epilepsy (past or present, including seizures or febrile convulsions) * Any surgical intervention to the brain * Heart diseases * Implanted medical devices (e.g., cochlear implants, infusion pumps, neurostimulators, pacemakers) * History of migraine or strong headaches * Sleep deprivation * Presence of non-MRI safe metal in the body * Drug or alcohol abuse * Intake of any medication that is likely to lower seizure threshold * Claustrophobia * For female participants: in order to participate in the study, female participants in reproductive age need to take a pregnancy test (a standard urine pregnancy test will be provided). * For female participants: breastfeeding * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, etc. of the participant * Lack of knowledge of the German language * Participation in another study with investigational drug within the 30 days preceding and during the present study * Previous enrolment into the current study * Enrolment of the investigator, his/her family members, employees and other dependent persons

Design outcomes

Primary

MeasureTime frameDescription
Age-related differences in the spatio-temporal patterns of signal propagation2 hoursThe spatiotemporal patterns of signal propagation, as measured with a combined TMS-hd-EEG approach, in younger and older healthy participants, reflecting age-related differences on the neural level.

Secondary

MeasureTime frameDescription
Association between the performance in a cognitive test battery and patterns of signal propagation in younger and older participants4 hoursThe association between the performance in a specific cognitive test and the aforementioned patterns of signal propagation in younger and older healthy participants, reflecting the functional significance of these age-related patterns on the cognitive level.
Association between the performance in a cognitive test battery and patterns of signal propagation in better- and worse-performers4 hoursThe association between the performance in a specific cognitive test and the aforementioned patterns of signal propagation in better- and worse-performers, reflecting the functional significance of these age-independent patterns on the cognitive level.
Association between the patterns of signal propagation and the structural properties of the white matter4 hoursThe association between the aforementioned patterns of signal propagation and the structural properties of the white matter interconnecting the involved cortical areas, as measured by DTI.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026